Social Business 16: Acemannan an Upstream Resource for Prevention

There is a modern problem that I probably do not need to spend time convincing you of because it’s so obvious. And that is this: there is a global epidemic of poor health and disease. And it’s associated with the way we who embrace Western medicine manage disease. The Atlantic Magazine reported that of the top 17 countries of the world, we rate last in life expectancy. But we’re number one in heart disease, stroke, cancer, diabetes and so forth. There are very few real solutions when chronic disease sets in. And it results in spending a fortune on the management of poor health. The problem is so large and growing that one source says that the price tag is presently at around $10.4 trillion, with a prediction of expanding to $30 trillion by the year 2030. This is inconceivable and certainly unsustainable. If economies are not already under duress, this one single area of fiscal concern can bankrupt world economies all by itself.

Medical insurance companies in full cooperation with big pharma have basically owned the sick care market. And these insurance companies, though they do show a limited amount of flexibility, they’re basically reticent to color outside the lines of the medical industry complex and do things like give support to alternative and functional medicine when we might choose to go that route. I know my boss pays for major medical for me, but I don’t use it in essence because it doesn’t cover the functional doctor I visit at least twice a year with the accompanying lab work. I pay out of pocket and is the reason I have to limit expanded lab work since I’m paying for it. I had been paying a portion of my medical insurance from my payroll check when I had a $500 deductible plan, but then I wanted not to do that. So I settled for a $5,000 deductible. And don’t get me wrong, if you’re in a car wreck, God forbid, you don’t want to be in a third-world country. The United States has the best support if that happens.

What seems to be getting a great deal of attention lately, even in allopathic medicine, is immunotherapy. Think monoclonal antibodies as an example. Plus during COVID, I heard it said that 1,000 nutraceutical products were making claim that they boost the immune system. I don’t know if that’s an exaggerated number or not, but the immune system got center stage in those days and still is. I mean, immunotherapy is coming on pretty strong. We’re kind of tired of the toxicity in our medications and the side effects that often turn into direct effects that increases the need for still more drugs. If you’re like me, you know people who take a literal handful of prescription drugs every single day, but there’s a growing number of proponents who are coming to common sense conclusions. Those who are finally thinking this through, that the best thing that’s ever happened to us physiologically is our immune system. That is where we should start and what we should build upon.

Meanwhile, we are subject to the increasing cost of medical insurance and employers are feeling this financial pressure as they pass on an ever-increasing amount of that expense to their employees. Entrepreneurs and families not covered with insurance by the good graces of an employment arrangement, in many cases, cannot afford the insurance and they for sure cannot afford to pay full price for medical attention.

What has surfaced in the last few decades are Christian-based non-profit organizations called health share programs. I participated in one back in the 1980s. Because these health share organizations are non-profit, that means the profit motive is taken out of the equation immediately. Of course, profit is a significant part of the mainstream medical insurance industry as that is one of their goals. But the goal of health share programs is to simply cover the cost of health share coverage according to their various options, and when they do so, that’s considered mission accomplished in their book.

And because that goal is not distracted with the profit motive, they can negotiate a cash price payout in a timely manner. Because they pay quickly and they pay in cash, the healthcare providers don’t have to go through what is sometimes months of red tape and explanations to justify various claims. Hence the red tape. As a result, the health share organization can acquire a much less expensive cost for the medical services rendered through negotiation and quick cash payments. The prices are more reasonable and the medical provider is relieved with an expedited payment. All of this translates into health coverage by health share members as costing much less than what they would normally spend if they had to pay for traditional medical insurance. The status quo is interrupted here just enough for a good idea to take root and people who want this kind of coverage are relieved with lower monthly expense.

By the way, let me make it clear, the health share program is not a health insurance policy. It is a membership. There are no agents, no contracts, and no brokers in the picture. However it is that the medical bills might get paid, evaluators of the medical insurance industry are saying that it needs to see the writing on the wall. It needs to ante up and conclude that it makes more sense to invest in people’s health than it does to cover the ever-increasing costs of their sickness.

This is but small indication of this possibility when David Cordani, president and CEO of Cigna Global Health Services said, “we have built a system that largely intervenes medically and with pharmaceuticals only once people are sick. That’s too late.” He went on to say, “our current system is too toxic, too expensive, too influenced by big pharma.” By the way, I checked, he still has his job. And notice that this was said in February 2020, just as the world was going into that COVID thing. Solely addressing medical issues downstream is just too expensive and can back patients into corners they don’t want to be in, both on physical and financial levels.

But there is one health share program who is taking an unprecedented step. That organization has made arrangements with the nutraceutical company I collaborate with. You become a member in this health share program through our portal. And in addition to everything I’ve covered so far, and then some, you also receive a free bottle of our Acemannan product every single month as part of the membership package for as long as you are in the program.

If you’ve been taking in my videos about Acemannan, you know I’m trying to impress upon you the incredible efficacy of this stabilized molecule from the aloe plant. There are many studies to back it up. When the board of directors at this health share organization started to glean this information I’m sharing with you, they were impressed enough to make Acemannan the product of choice to lead the way in this extraordinary attempt to address the immune systems of their members. An upstream attempt at prevention.

So when the board of directors of the health share organization met with Sam Caster, they were meeting not only with the man who brought Acemannan to market initially, but with the man who had asked the question of the scientist that the board of directors were also very much interested in. The board needed to know that the best possible single ingredient they were giving to their members monthly was the most effective. Well the question had already been queried by Sam of the scientists who were ecstatic over the discovery of Acemannan in the 1980s. Plus Sam had put Acemannan to the test over a 20 year market presence by this time. That question is, if I take this to market, what else out there in the market might be my competition? The board of directors was asking a similar question. If we fold this into our health share program, is it the best possible option for optimizing the immune system of our members? Or is there something else out there? Early on, when Sam made plans to enter the market with Acemannan, he had wondered if the competition might exist in some exotic mushroom or unique herbal blend or miracle essential oil. He needed to know what other possible ingredient or molecule might be in the market that does what Acemannan does. The answer from the scientist was that there was nothing else, except for one thing: breast milk.

Just like the polysaccharide Acemannan breaks down into mannose in the body when consumed, breast milk is also replete with mannose to nourish and establish the immune system in the early days and weeks of life. As Bill McAnally in his book The Science Behind Aloe points out in an entire section dedicated to breast milk as a prototype for Acemannan, he said that the importance of mannose is further illustrated by the fact that the intestine has specific pumps designed to move mannose from the intestine into the blood. McAnally drives the point home tapping a study by Cavilli et al. in 2006 that established that human breast milk contains a significant concentration of free mannose, which can serve as the main source of mannose for infants.

I’ll say it clearly, Acemannan more than holds its own and hundreds of studies confirm this. It is totally non-toxic and nothing functions like it in nature. In simplest of terms, it optimizes the immune system response. If you get sick, recovery time is likely to be faster if the immune system is optimized against the invader. And that’s what Acemannan does in spades.

No single molecule or supplement could better support the one thing that is the best thing that’s happened to us, our immune system. No other part of the medical insurance or health share industry has found the incentive to do this until now.

The general practice of open enrollment to your employer’s medical insurance plan takes place at the end of each year. If your shared expense in your employer’s insurance plan is getting too high or you pay for private insurance, you’ll want to know more.

Meanwhile, I hope you will always be careful to maintain good works to meet urgent needs and become heroes to your generation.